IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 122 filers reported holding IVERIC BIO INC in Q4 2020. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $39,105,416 | +64.4% | 994,037 | +1.7% | 0.01% | +57.1% |
| Q1 2023 | $23,781,456 | +15.2% | 977,454 | +1.4% | 0.01% | 0.0% |
| Q4 2022 | $20,646,969 | +39.6% | 964,361 | +17.0% | 0.01% | +40.0% |
| Q3 2022 | $14,786,000 | +409.0% | 824,153 | +173.0% | 0.01% | +400.0% |
| Q2 2022 | $2,905,000 | -42.7% | 301,888 | +0.2% | 0.00% | -50.0% |
| Q1 2022 | $5,070,000 | +2.8% | 301,216 | +2.1% | 0.00% | +100.0% |
| Q4 2021 | $4,932,000 | +15.1% | 294,930 | +11.8% | 0.00% | 0.0% |
| Q3 2021 | $4,284,000 | +199.8% | 263,737 | +16.5% | 0.00% | – |
| Q2 2021 | $1,429,000 | +12.1% | 226,411 | +9.7% | 0.00% | – |
| Q1 2021 | $1,275,000 | -8.3% | 206,306 | +2.6% | 0.00% | -100.0% |
| Q4 2020 | $1,391,000 | +22.6% | 201,169 | -0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,135,000 | +108.6% | 201,233 | +88.8% | 0.00% | – |
| Q2 2020 | $544,000 | +1294.9% | 106,608 | +263.1% | 0.00% | – |
| Q2 2019 | $39,000 | – | 29,361 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |